Orion Oyj (OTCMKTS:ORINF) Short Interest Up 24.9% in February

Orion Oyj (OTCMKTS:ORINF) saw a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 623,300 shares, an increase of 24.9% from the February 13th total of 498,900 shares. Based on an average daily trading volume, of 300 shares, the short-interest ratio is currently 2,077.7 days.

Orion Oyj Price Performance

Shares of OTCMKTS:ORINF opened at $48.65 on Wednesday. Orion Oyj has a 12-month low of $48.65 and a 12-month high of $48.65. The business’s 50 day moving average is $48.65 and its 200 day moving average is $47.99.

About Orion Oyj

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.